What happened
Samsung Biologics updated the terms of a new share issuance to raise US$2.21B, about 5.0% of its market value.
For context, this raise equals about 5.0% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$2.21B |
| vs. market value | 5.0% |
| Filed | 2026-10-01, [Amended] Material event report (rights offering) |
| Source | DART rcept 20261001000449 → open original filing |
Versions of this filing
- 2026-08-28Original
- 2026-10-01Amendment 1 (this page)
Source: DART. Information only, not investment advice.